News
Company News
From DNA to Discovery: GCATbio’s End-to-End Synthetic Biology Solutions
Powered by proprietary mMPS technology, GCATbio delivers the scalable DNA synthesis capabilities to turn ambitious biological designs into reality—advancing the frontiers of medicine, genomics, and biomanufacturing.
2025-12-25
Decoding Nature’s 10: Ten People Who Helped Shape Science in 2025
The 2025 Nature’s 10 exemplifies a global shift from laboratory hypothesis to precision engineering. As a builder of DNA infrastructure, GCATbio leverages high-throughput synthesis to transform visionary concepts—from 'N-of-1' therapies to ecological shields—into scalable realities.
2026-01-15
